LONDON, ONTARIO -- (MARKET WIRE) -- February 26, 2007 -- Stellar Pharmaceuticals Inc. (TSX VENTURE: SLX)(OTCBB: SLXCF) (“Stellar” or “the Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that Mr. John M. Gregory, RPH founder and former CEO of King Pharmaceuticals has agreed to join the Stellar board as a new director. John is the founder and managing partner of SJ Strategic Investments LLC, which is the largest shareholder of Stellar, holding 5,188,794 shares which represents approximately 21.8% of the Company’s shares on a non-diluted basis. As a director of the company John will be able to take a more active role in Stellar’s future.
